I25.739 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris

Name of the Condition

• Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
• ICD-10 Code: I25.739

Summary

Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris refers to plaque buildup in nonautologous biological grafts used in coronary artery bypass surgery, leading to reduced blood flow and chest pain (angina pectoris) without further specification. This condition occurs when narrowing of the grafts impairs blood supply to the heart muscle, potentially causing symptoms and complications related to ischemia.

Causes

Atherosclerosis in nonautologous biological grafts typically results from plaque accumulation, which includes cholesterol, fatty deposits, and cellular debris. Contributing factors may include chronic inflammation, endothelial dysfunction, and the natural progression of vascular disease over time.

Risk Factors

• History of coronary artery bypass surgery using nonautologous biological grafts.
• Pre-existing atherosclerosis or cardiovascular disease.
• Lifestyle factors such as smoking, poor diet, and physical inactivity.
• Conditions like diabetes, high blood pressure, or high cholesterol.

Symptoms

• Chest pain or discomfort (angina), often triggered by exertion or stress.
• Shortness of breath or fatigue during physical activity.
• Possible radiation of pain to the arm, neck, or jaw.

Diagnosis

Diagnosis involves assessing symptoms, medical history, and results from diagnostic tests. Electrocardiograms (ECGs) may show signs of ischemia. Stress tests or imaging studies like coronary angiography can evaluate blood flow through the grafts. Blood tests may check for markers of heart damage or risk factors like cholesterol levels.

Treatment Options

Treatment focuses on managing symptoms and reducing cardiovascular risk. Medications may include antiplatelet agents, statins, beta-blockers, or nitrates. Lifestyle modifications such as diet, exercise, and smoking cessation are recommended. In severe cases, revascularization procedures like angioplasty or repeat bypass surgery may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of graft narrowing, overall heart function, and response to treatment. Regular follow-up with a cardiologist is essential to monitor symptoms, adjust medications, and assess graft patency. Lifestyle changes and adherence to treatment plans can improve outcomes.

Complications

Complications may include myocardial infarction (heart attack), heart failure, arrhythmias, or graft failure. Reduced blood flow can lead to permanent heart muscle damage if not addressed promptly.

Lifestyle & Prevention

• Adopt a heart-healthy diet low in saturated fats and cholesterol.
• Engage in regular physical activity as recommended by a healthcare provider.
• Quit smoking and avoid secondhand smoke.
• Manage conditions like diabetes, hypertension, or high cholesterol with medication and lifestyle changes.
• Attend regular medical check-ups to monitor cardiovascular health.

When to Seek Professional Help

Seek immediate medical attention for severe or worsening chest pain, shortness of breath, dizziness, or signs of a heart attack (e.g., pain radiating to the arm or jaw). Contact a healthcare provider for persistent angina or new symptoms between check-ups.

Tips for Medical Coders

When coding I25.739, ensure documentation specifies atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris without further classification (e.g., stable, unstable, or with spasm). Verify that the angina is not documented as a specific type to justify this code. Confirm the use of nonautologous biological grafts in prior bypass surgery and link the angina to graft-related ischemia.